Do you have questions regarding the new HPV vaccine, Gardasil?

Viral Marketing: Questions on Efficacy Cloud a Cancer Vaccine
Merck Predicts Big Fall In Cervical Lesions, But Data Are Complex
by John Carreyrou, The Wall Street Journal, Apr 16, 2007

Eliav Barr, the head of Merck's HPV vaccine program, says Gardasil is a "lifesaving" vaccine and its widespread adoption will result in "a substantial decline in the rate of cervical cancer." Dr. Barr says Merck provided "an extremely strong dossier" on Gardasil that both the FDA and the CDC have deemed satisfactory. But behind the scenes, Gardasil has been dogged by uncertainty about how effective it really is.

For more information regarding Merck & Co.'s Gardasil vaccine, please download the full article at the Wall Street Journal's web site or contact our office.